We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

As you can see from the chart above the percentage of shares that are sold short for Elevance Health has declined since its last report. This does not mean that the stock is going to rise in the ...

Elevance Health (ELV) stock is one of the worst S&P 500 stocks in Thursday's session. The selloff comes after the health insurance company missed bottom-line expectations for its third quarter and ...

Elevance Health (NYSE: ELV) presented at the Barclays ... to materially impact earnings due to the cost-plus contract structure. Elevance expects over 60% of its adjusted earnings per share ...